Alkem Laboratories 미래 성장
Future 기준 확인 1/6
Alkem Laboratories (는) 각각 연간 10.6% 및 9.4% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 10.5% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 18.6% 로 예상됩니다.
주요 정보
10.6%
수익 성장률
10.5%
EPS 성장률
| Pharmaceuticals 수익 성장 | 18.3% |
| 매출 성장률 | 9.4% |
| 향후 자기자본 수익률 | 18.6% |
| 애널리스트 커버리지 | Good |
| 마지막 업데이트 | 15 Nov 2024 |
최근 미래 성장 업데이트
Alkem Laboratories Limited Recorded A 5.4% Miss On Revenue: Analysts Are Revisiting Their Models
Nov 16
Earnings Beat: Alkem Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Aug 13Alkem Laboratories Limited (NSE:ALKEM) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
Jun 01Alkem Laboratories Limited (NSE:ALKEM) Just Reported And Analysts Have Been Lifting Their Price Targets
Feb 13Recent updates
Alkem Laboratories Limited Recorded A 5.4% Miss On Revenue: Analysts Are Revisiting Their Models
Nov 16Here's Why We Think Alkem Laboratories (NSE:ALKEM) Is Well Worth Watching
Nov 15What Alkem Laboratories Limited's (NSE:ALKEM) P/E Is Not Telling You
Sep 24Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?
Sep 03Earnings Beat: Alkem Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Aug 13Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year
Jul 27Alkem Laboratories' (NSE:ALKEM) Dividend Will Be Reduced To ₹5.00
Jul 13Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year
Jun 27Alkem Laboratories (NSE:ALKEM) Has Announced That Its Dividend Will Be Reduced To ₹5.00
Jun 13Alkem Laboratories Limited (NSE:ALKEM) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
Jun 01Earnings Tell The Story For Alkem Laboratories Limited (NSE:ALKEM)
May 22Alkem Laboratories Limited (NSE:ALKEM) Just Reported And Analysts Have Been Lifting Their Price Targets
Feb 13Investors Appear Satisfied With Alkem Laboratories Limited's (NSE:ALKEM) Prospects
Jan 17We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease
Dec 27Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?
Sep 14Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year
Aug 02Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year
Jul 07Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year
May 22We Think Alkem Laboratories (NSE:ALKEM) Can Stay On Top Of Its Debt
Mar 27Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?
Dec 26These 4 Measures Indicate That Alkem Laboratories (NSE:ALKEM) Is Using Debt Reasonably Well
Sep 20Alkem Laboratories' (NSE:ALKEM) Dividend Is Being Reduced To ₹4.00
Jul 27Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year
Jul 13Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?
Jun 11Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?
May 23Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?
Mar 06Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?
Feb 21수익 및 매출 성장 예측
| 날짜 | 수익 | 수익 | 잉여 현금 흐름 | 작전 현금 | 평균 애널리스트 수 |
|---|---|---|---|---|---|
| 3/31/2027 | 161,346 | 27,516 | 19,790 | 23,269 | 19 |
| 3/31/2026 | 147,401 | 25,256 | 16,921 | 21,438 | 22 |
| 3/31/2025 | 133,577 | 22,434 | 15,906 | 25,062 | 22 |
| 9/30/2024 | 128,319 | 21,223 | 15,054 | 19,549 | N/A |
| 6/30/2024 | 127,317 | 20,542 | N/A | N/A | N/A |
| 3/31/2024 | 126,676 | 17,958 | 16,888 | 19,481 | N/A |
| 12/31/2023 | 126,344 | 15,732 | N/A | N/A | N/A |
| 9/30/2023 | 123,514 | 14,329 | 18,370 | 20,537 | N/A |
| 6/30/2023 | 119,906 | 11,433 | N/A | N/A | N/A |
| 3/31/2023 | 115,993 | 9,842 | 14,496 | 16,825 | N/A |
| 12/31/2022 | 111,805 | 10,208 | N/A | N/A | N/A |
| 9/30/2022 | 107,586 | 10,917 | 5,527 | 8,426 | N/A |
| 6/30/2022 | 104,792 | 13,051 | N/A | N/A | N/A |
| 3/31/2022 | 106,342 | 16,456 | 7,721 | 11,110 | N/A |
| 12/31/2021 | 103,425 | 17,780 | N/A | N/A | N/A |
| 9/30/2021 | 100,416 | 17,033 | 10,478 | 13,213 | N/A |
| 6/30/2021 | 96,044 | 16,311 | N/A | N/A | N/A |
| 3/31/2021 | 88,650 | 15,850 | 11,051 | 12,649 | N/A |
| 12/31/2020 | 87,218 | 15,338 | N/A | N/A | N/A |
| 9/30/2020 | 85,971 | 14,648 | 8,916 | 11,455 | N/A |
| 6/30/2020 | 84,984 | 13,636 | N/A | N/A | N/A |
| 3/31/2020 | 83,444 | 11,271 | 2,220 | 5,851 | N/A |
| 12/31/2019 | 81,484 | 11,057 | N/A | N/A | N/A |
| 9/30/2019 | 78,929 | 9,262 | 5,173 | 8,756 | N/A |
| 6/30/2019 | 75,478 | 8,098 | N/A | N/A | N/A |
| 3/31/2019 | 73,572 | 7,605 | 2,505 | 7,797 | N/A |
| 12/31/2018 | 70,157 | 6,602 | N/A | N/A | N/A |
| 9/30/2018 | 68,318 | 6,293 | N/A | N/A | N/A |
| 6/30/2018 | 67,788 | 6,955 | N/A | N/A | N/A |
| 3/31/2018 | 63,918 | 6,309 | N/A | 2,660 | N/A |
| 12/31/2017 | 60,044 | 7,009 | N/A | N/A | N/A |
| 9/30/2017 | 57,285 | 7,626 | N/A | N/A | N/A |
| 6/30/2017 | 55,019 | 7,248 | N/A | N/A | N/A |
| 3/31/2017 | 56,875 | 8,920 | N/A | 4,711 | N/A |
| 12/31/2016 | 56,933 | 7,732 | N/A | N/A | N/A |
| 9/30/2016 | 54,992 | 7,267 | N/A | N/A | N/A |
| 6/30/2016 | 52,419 | 7,108 | N/A | N/A | N/A |
| 3/31/2016 | 49,248 | 7,416 | N/A | 7,258 | N/A |
| 12/31/2015 | 47,975 | 8,189 | N/A | N/A | N/A |
| 9/30/2015 | 44,556 | 7,227 | N/A | 4,023 | N/A |
| 6/30/2015 | 40,459 | 5,781 | N/A | N/A | N/A |
| 3/31/2015 | 37,434 | 3,916 | N/A | 3,255 | N/A |
| 3/31/2014 | 31,191 | 4,353 | N/A | 2,900 | N/A |
애널리스트 미래 성장 예측
수입 대 저축률: ALKEM 의 연간 예상 수익 증가율( 10.6% )이 saving rate( 6.7% 보다 높습니다. ).
수익 vs 시장: ALKEM 의 연간 수익( 10.6% ) Indian 시장( 17.9% 보다 느리게 성장할 것으로 예상됩니다. 17.9% 연간).
고성장 수익: ALKEM 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.
수익 대 시장: ALKEM 의 수익(연간 9.4% ) Indian 시장( 10.5% 보다 느리게 성장할 것으로 예상됩니다. 10.5% 연간).
고성장 수익: ALKEM 의 수익(연간 9.4% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.
주당 순이익 성장 예측
미래 자기자본 수익률
미래 ROE: ALKEM 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 18.6 %).